We pass on our knowledge to others through wide range of our own educational programs. According to the World Health Organization, 15 million people suffer stroke worldwide each year. A first-in class antithrombotic agent Our drug candidate is an antithrombotic agent, designed to reduce the size of the clot, prevent recurrences without bleeding risk and is intended to be used within the first 12 hours. This unbranched polysaccharide has a variety of biological effects offering advances in pharmacy and medicine. Unmeet medical needs in acute stroke Despite some health and economic needs, no pharmaceutical treatment is currently satisfactory for the treatment of stroke. Despite some health and economic needs, no pharmaceutical treatment is currently satisfactory for the treatment of stroke. Stroke is the 3rd cause of death in industrialized countries 6 million deaths worldwide. The most important strength is our own basic and applied research, which is handled by half of our employees. Find out more about veterinary pharmaceuticals and medical devices designed with deep insight into the biology of tissues. Contrairement aux thérapies existantes, ce candidat-médicament …. Leader in hyaluronic acid research Our mission is to deeply understand hyaluronic acid.
Today bone marrow transplants are complicated, toxic and high-risk. We are working to change that for patients with autoimmune diseases, blood cancers, and rare genetic diseases. Virginia BioTechnology Research Park – BioTech One E. Leigh St. About. BioTech One is home to VCU’s Office of Research and Innovation and its affiliates. The building also houses the Virginia Institute for Psychiatric and Behavioral Genetics, as well as other BioTech Park tenants. Like all BioTech USA products, CreaTrans consists of safe and carefully selected ingredients. Directions Mix 1 serving (40 g = 1 scant measuring spoon = 3 heaped tablespoons) with ml water in a shaker. about us WE ARE INNOVATIVE Bonti is a clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin products for therapeutic and aesthetic applications.